Results 211 to 220 of about 119,004 (251)

Expanding the Phenotype of PARK‐PRKN to Spastic Paraplegia: A Report of Two Cases

Movement Disorders Clinical Practice, Volume 13, Issue 10, Page 2626-2628, October 2026.
Nicolas Geoffre, Thomas Ollivier, Guillaume Baille, Luc Defebvre, Vincent Huin, Eugenie Mutez   +5 more
wiley   +1 more source

A Retrospective Descriptive Analysis of Consultations Provided by the National Poisons Centre Relating to Medicines on the Aotearoa New Zealand Antidote Stocking Guideline, 2020–2025

Emergency Medicine Australasia, Volume 38, Issue 5, October 2026.
ABSTRACT Objective Many antidotes are relatively rare‐use, indication‐specific medicines with a variable evidence base. In Aotearoa New Zealand, there are no national statistics available on their use. This study aimed to characterize the numbers of cases and advice provided by the Aotearoa New Zealand National Poisons Centre (NZNPC) on the use of true
Eeva‐Katri Kumpula, William Boroughf
wiley   +1 more source

Botulinum Toxin Treatment in Musician's Dystonia: Long-Term-Effects and Influencing Factors. [PDF]

Toxins (Basel)
Plinkert TA, Doll-Lee J, Passarotto E, Ioannou CI, Altenmüller E, Lee A.   +5 more
europepmc   +1 more source

A Swedish Population‐Based Study Found That Muscle Hypertonia in Children With Cerebral Palsy Varied by Age, Subtype, Functional Level, and Muscle Group

Acta Paediatrica, Volume 115, Issue 10, Page 2261-2268, October 2026.
ABSTRACT Aim We examined how lower limb muscle tone was related to age, sex, Gross Motor Function Classification System (GMFCS) level, and the cerebral palsy (CP) subtype in Swedish children with CP. Methods This registry‐based cohort study from 2023 to 2024 used data on all 3 216 children aged 1–15 from the Swedish follow‐up program and national CP ...
Gunnar. Hägglund, Ann. I. Alriksson‐Schmidt   +1 more
wiley   +1 more source

Pain-Specific Benefits of Higher-Dose Neubotulinum Toxin Type A in Cervical Dystonia: A Multicenter Randomized Double-Blind Crossover Trial. [PDF]

Toxins (Basel)
Arayawichanont A, Kongsaengdao S.
europepmc   +1 more source

Migraine in Older Adults: Age‐Related Clinical Features From the Italian RICe Registry

European Journal of Neurology, Volume 33, Issue 10, October 2026.
This multicentre study of 3477 patients from 30 Italian headache centres identified distinct age‐related patterns in migraine. Older adults more frequently presented with chronic migraine, higher monthly migraine frequency, lower pain intensity, and medication‐overuse headache, as well as distinct trigger and preventive treatment patterns.
Giulia Paparella, Luigi Francesco Iannone, Giulia Paparella, Grazia Sances, Roberto De Icco, Gloria Vaghi, Cristina Tassorelli, Andrea Burgalassi, Francesco De Cesaris, Alberto Chiarugi, Francesca Gabriele, Raffaele Ornello, Simona Sacco, Maria Pia Prudenzano, Martino Gentile, Damiano Paolicelli, Giorgia Dalla Volta, Marco Bolchini, Innocenzo Rainero, Elisa Rubino, Maria Albanese, Fabrizio Vernieri, Gianluca Coppola, Gianluca Avino, Edoardo Mampreso, Delfina Ferrandi, Marta Altieri, Stefania Battistini, Antonio Granato, Simona Guerzoni, Antonio Russo, Marina de Tommaso, the RICe Study Group, Paola Merlo, Alessandro Viganò, Massimo Alessandri, Lucia Princiotta Cariddi, Milena Taglioli, Mariarosaria Valente, Rosaria Rapisarda, Alessandro Tiezzi, Giovanna Ballerini, Giovanna Viticchi, Catello Vollono, Luisa Fofi, Antonio Montisano, Licia Grazzi, Eugenia Rota   +47 more
wiley   +1 more source

In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A. [PDF]

Toxins (Basel)
Nam JS, Yoon D, Kim Y, Kim SY, Kim JY, Cha Y, Seok J, Kim BJ.   +7 more
europepmc   +1 more source

Framework for headache management in pediatric patients with stroke and cerebrovascular lesions: A narrative review

Headache: The Journal of Head and Face Pain, Volume 66, Issue 9, Page 2138-2155, October 2026.
Abstract Objective To present a practical, evidence‐based framework for the management of headache disorders in pediatric patients with prior stroke or underlying cerebral vascular lesions, with particular attention to safety and efficacy of pharmacologic and non‐pharmacologic therapies.
Allison C. Hyland, Samuel J. Belfer, Christine K. Fox, Samantha L. Irwin, Rachel Vassar, Ann Oh, Sruthi Ilangovan, Amy A. Gelfand   +7 more
wiley   +1 more source

Early Treatment of Post-Stroke Spasticity with Botulinum Toxin Type A: Myth or Reality? [PDF]

Toxins (Basel)
Picelli A, Di Censo R, Smania N, Varalta V, Filippetti M.   +4 more
europepmc   +1 more source